CB vs REPL
Chubb Ltd (CB) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
REPL does not have a complete income-statement cache yet.
CB currently screens at market cap $114.26B and trailing P/E 13.7. REPL currently screens at market cap $825.7M.
Not investment advice. Open the CB and REPL stock pages for the full models.
Not investment advice.